shares of china resources sanjiu medical  pharmaceutical co jumped on tuesday as investors welcomed the chinese drug makers latest step forward with its 290 billion yuan 4023 million acquisition of a stake in another pharma company the stock gained as much as 66 and was last up 47 at cny5780 at the midday trading break the upturn came after china resources sanjiu early tuesday posted an independent financial advisor report on its proposed deal to buy about 212 million shares in fellow drug maker kpc pharmaceuticals inc for cny1367 each that marked significant progress toward finalizing the transaction after months of pandemicrelated delays the deal is still subject to approval by shareholders and regulators china resources sanjiu one of the countrys largest pharmaceutical developers first announced the deal in may after it closes the company will hold a 28 stake in kpc and count it as a subsidiary